Medicon Valley Alliance and Bruker Daltonics would like to welcome you to a Boost Seminar 28th of October 2026. Modern biologics demand a deeper understanding of molecular structure, heterogeneity, and product quality throughout development and manufacturing. This seminar highlights advanced analytical strategies for comprehensive characterization of biotherapeutics, including peptide mapping, protein sequence verification, higher-order structural […]

The Nordic arena for early clinical trials attracts pharmaceutical companies from all over the world. What they seek is high quality trials performed by high performing sites. What can the Nordic countries provide and how can companies within the Medicon Valley make best use of the expertise available right on our doorstep? This seminar aims […]

17 April 2012 / Ørestad / Denmark Medicon Valley Alliance in cooperation with DNB invites you to participate in a network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present you technology / business plan to any of the […]

This seminar will address several of todays key challenges in drug development leading up to clinical proof of concept. The agenda brings together a panel of speakers from academia, pharmaceutical companies and solution providers to discuss key issues from formulation design right through to effective clinical trial planning. The final session w ill discuss how […]

Organotypic 3D-cell-culture systems are implemented at various stages in the compound development process for de-risking new drug candidates and can provide a wealth of meaningful efficacy and toxicology data. A growing list of publications confirms the striking similarities of these systems to in vivo tissue, clearly underlining their high potential value to the pharmaceutical industry. […]